全文获取类型
收费全文 | 486篇 |
免费 | 11篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 13篇 |
妇产科学 | 2篇 |
基础医学 | 119篇 |
口腔科学 | 8篇 |
临床医学 | 54篇 |
内科学 | 61篇 |
皮肤病学 | 10篇 |
神经病学 | 38篇 |
特种医学 | 6篇 |
外科学 | 50篇 |
综合类 | 38篇 |
预防医学 | 35篇 |
眼科学 | 16篇 |
药学 | 30篇 |
中国医学 | 2篇 |
肿瘤学 | 24篇 |
出版年
2022年 | 3篇 |
2021年 | 8篇 |
2018年 | 4篇 |
2016年 | 3篇 |
2015年 | 10篇 |
2014年 | 20篇 |
2013年 | 14篇 |
2012年 | 14篇 |
2011年 | 14篇 |
2010年 | 9篇 |
2009年 | 16篇 |
2008年 | 8篇 |
2007年 | 22篇 |
2006年 | 22篇 |
2005年 | 11篇 |
2004年 | 11篇 |
2003年 | 20篇 |
2002年 | 17篇 |
2001年 | 19篇 |
2000年 | 16篇 |
1999年 | 20篇 |
1998年 | 13篇 |
1997年 | 13篇 |
1996年 | 14篇 |
1995年 | 5篇 |
1994年 | 9篇 |
1993年 | 7篇 |
1992年 | 13篇 |
1991年 | 11篇 |
1990年 | 10篇 |
1989年 | 8篇 |
1988年 | 5篇 |
1987年 | 15篇 |
1986年 | 8篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1979年 | 5篇 |
1975年 | 4篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 6篇 |
1970年 | 3篇 |
1969年 | 5篇 |
1968年 | 4篇 |
1967年 | 3篇 |
1966年 | 5篇 |
1965年 | 3篇 |
1959年 | 7篇 |
排序方式: 共有507条查询结果,搜索用时 312 毫秒
61.
62.
63.
BINNUR TÜZÜN M.D. YALÇIN TÜZÜN M.D. NURAY GÜREL M.Sc . NÜKHET TÜZÜNER M.D. TUNCAY ALTUG Ph .D. SEVIM BÜYÜKDEVRIM M.D. 《International journal of dermatology》1993,32(2):133-134
Background. β-Blockers cause a psoriasiform eruption. We investigated the skin effects of systemic propranolol in a formal protocol. Methods. Propranolol, 0.1 mg/day, was used systemically by gavage in eight albino guinea pigs. Normal saline was given to another group of seven guinea pigs. Results. Propranolol produced psoriasiform lesions in five of seven guinea pigs on the 30th day. Biopsies showed acanthosis, parakeratosis, microabscesses, and cellular infiltration of upper dermis. Topical application of propranolol did not produce clinical psoriasiform changes, while acanthosis and papillomatosis was observed in six of the six guinea pigs. Conclusions. Systemically given propranolol can lead to psoriasis-like lesions, which might be due to a serum factor. 相似文献
64.
65.
A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future use 总被引:9,自引:0,他引:9
Kenny T; Wilson RG; Purves IN; Clark J Sr; Newton LD; Newton DP; Moseley DV 《Family practice》1998,15(5):471-479
This article reviews the usefulness and importance of written information,
specifically leaflets, being given to patients. Evidence suggesting how
both patient and doctor may benefit from the giving of written information
is reviewed. Identification of good practice relating to the content and
readability of leaflets is discussed. An argument is put forward that the
giving of written information is an under-utilized resource in contributing
to improving patient outcomes but that this may be changing with the
increasing use of patient leaflet databases. The advantages and
disadvantages of computer- generated patient leaflets are discussed and
desirable further areas of research on computer-generated leaflets are
proposed.
相似文献
66.
The cholinergic system plays an importantrole in the control of heart rate and myocardialcontractility[1] .The inotropic and chronotropic ef-fects are partly regulated by the cytosolic Ca2 + lev-el( [Ca2 + ]i) .Muscarine receptor agonist,Arecol-ine ( Are) ,is a kind of alkaloid extracted from theseeds of areca.It had been reported that Are hadnegative inotropic and negative chronotropic effectson isolated guinea pig atria[2 ] ,but its effects oncalcium mobilization was unclear. In order to i… 相似文献
67.
Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis. 总被引:4,自引:2,他引:2
van Rensburg CJ Honiball PJ Grundling HD van Zyl JH Spies SK Eloff FP Simjee AE Segal I Botha JF Cariem AK Marks IN Theron I Bethke TD 《Alimentary pharmacology & therapeutics》1996,10(3):397-401
BACKGROUND: Pantoprazole is a substituted benzimidazole which is a potent inhibitor of gastric acid secretion by its action upon H+, K+- ATPase. METHODS: Pantoprazole 40 mg and 80 mg were compared in a randomized double-blind study in 192 out-patients with stage II or III (Savary-Miller classification) reflux oesophagitis. Patients received either pantoprazole 40 mg (n = 97) or pantoprazole 80 mg (n = 95), once daily before breakfast for 4 weeks. Treatment was extended for a further 4 weeks if the oesophagitis had not healed. RESULTS: After 4 weeks complete healing of the reflux oesophagitis was seen in 78% of protocol-correct patients given pantoprazole 40 mg daily (n = 86), and in 72% in the 80 mg (n = 87) group. The cumulative healing rates after 8 weeks were 95 and 94%, respectively (P > 0.05, Cochran-Mantel- Haenszel), and time until healing of oesophagitis comparable in both groups. Differences between doses were also not significant in an intention-to-treat analysis. Both dosing schedules were well tolerated and the patients experienced remarkable symptom relief. No adverse event or changes in laboratory values of clinical significance could definitely be ascribed to the trial medication. CONCLUSION: The 40 mg pantoprazole dosage is comparable to 80 mg in reflux oesophagitis, both in efficacy and tolerability. 相似文献
68.
I. V. Arutjunjan A. V. Volkov T. B. Bukharova P. V. Zelenkov N. A. Konovalov A. A. Rzhaninova I. N. Shevelev D. V. Goldshtein 《Bulletin of experimental biology and medicine》2008,146(4):501-505
We present an injection form of tissue-engineering construct on the basis of autogenous human chondroblasts for regeneration
of the cartilaginous tissue. A material meeting the requirements for the creation of the injection form of an ITC construct
(injectable chondrocyte transplantation) was used as the matrix carrier. The developed construct on the basis of autogenous
human chondroblasts and homogenized hemostatic gelatin sponge is now at the stage of complex experimental testing.
Translated from Kletochnye Tehnologii v Biologii i Meditsine, No. 4, pp. 183–187, November, 2008 相似文献
69.
70.